The Pfizer corporation announced on Tuesday that its officials had inked a licensing agreement which will enable less wealthy nations to distribute its antiviral drug Paxlovid in the form of generic anti-Covid pills. Pfizer, based out of New York City, agreed to allow generic drug manufacturers to produce their own Paxlovid pills at a much […] Read the full story on GreekReporter.com.